Month: July 2020

Formpipe has today completed the previously announced acquisition of EFS Technology Ltd. (EFS). The transaction was announced in a press release on July 6, 2020.The purchase price for 100 % of the shares was paid in cash and amounted to 6 million British pounds (GBP). The acquisition has been financed through a combination of own cash and loans.For additional information, contact:Christian Sundin, President and CEO of Formpipe, +46 705 67 73 85________________________________________________________________This is a translation of the original Swedish version. In the event of any discrepancies between the two versions, the original Swedish version shall take precedence.Formpipe develops ECM products and solutions for structuring information and supplies them to major companies, authorities and organisations. ECM products help organisations...

Formpipe har idag slutfört det tidigare kommunicerade förvärvet av EFS Technology Ltd. (EFS). Transaktionen offentliggjordes genom pressmeddelande den 6 juli 2020.Köpeskillingen för 100 % av aktierna erlades kontant och uppgick till 6 miljoner brittiska pund (GBP). Förvärvet har finansierats genom en kombination av egen kassa och lån.För ytterligare information, kontakta:Christian Sundin, vd och koncernchef för Formpipe, +46 705-67 73 85_________________________________________________________Formpipe utvecklar och levererar ECM-produkter och lösningar för att strukturera information i större företag, myndigheter och organisationer. ECM-produkter hjälper organisationer att fånga, hantera, distribuera och sätta information i ett sammanhang. Bolagets programvaror skapar ökad effektivitet, sänkta kostnader och minskad riskexponering. Formpipe...

AB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 900 000 000 EUR; ISIN codes XS1646530565; XS1853999313; XS2177349912.Preliminary financial data of Ignitis Group for 6 months of 2020:In January – June 2020, Ignitis Group generated revenue of EUR 590.9 million, which is 6,0 % more compared to a respective period of 2019 (EUR 557.5 million). The Group’s revenue has increased mainly due to price of power distribution service, which is comprised of power transmission, distribution and public service obligations (PSO) components.The adjusted EBITDA indicator of the Group in January – June 2020 was equal to EUR 128.7 million, i.e. 3.2 % less compared to a respective period of 2019 (EUR 132.9...

AB „Ignitis grupė“ (toliau – Bendrovė),  juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra AB „Ignitis grupė“ išleistų obligacijų nominali vertė 900 000 000 EUR; ISIN kodai: XS1646530565; XS1853999313; XS2177349912.2020 metų 6 mėnesių preliminarūs „Ignitis grupės“ įmonių grupės (toliau – Grupės) finansiniai duomenys:Grupės pajamos 2020 m. sausio-birželio mėn. siekė 590,9 mln. eurų ir buvo 6,0 proc. didesnės palyginus su atitinkamu laikotarpiu 2019 m. (557,5 mln. eurų). Esminė Grupės pajamų augimą lėmusi priežastis buvo elektros energijos persiuntimo paslaugos, kurią sudaro elektros perdavimo, skirstymo ir viešuosius interesus atitinkančių paslaugų (VIAP) dedamosios, kaina.Grupės koreguotas EBITDA rodiklis 2020 m. sausio-birželio mėn. siekė 128,7 mln. eurų ir buvo 3,2 proc. mažesnis palyginus...

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company to proceed with a randomized, double-blind, placebo-controlled confirmatory Phase 3 clinical trial protocol to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.“The FDA approval of the Phase 3 study to evaluate Bucillamine in the treatment of patients with mild-moderate COVID-19 is a tremendous milestone for Revive and I am very proud of the dedication of our team and partners to bring forward a potential new treatment option for patients with...

NORTH CONWAY, N.H., July 31, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Northway Financial, Inc. (OTCQB: NWYF), please note that the dividend dates in the second paragraph were changed from August 10, 2020 and August 3, 2020 to August 17, 2020 and August 10, 2020. The corrected release follows:Northway Financial, Inc. (the “Company”) (OTCQB: NWYF), the parent company of Northway Bank (the “Bank”), today reported net income for the quarter ended June 30, 2020 of $2.3MM, or $0.84 per basic common share. Year-to-date, the Company reported net income of $923M, or $0.34 per basic common share.The Board of Directors has declared a semi-annual cash dividend of $0.35 per share, payable on August 17, 2020, to common stockholders of record on August 10, 2020. Based on a share price of $23.35 on July...

SHREVEPORT, La., July 31, 2020 (GLOBE NEWSWIRE) — Home Federal Bank (“HFB”), the wholly-owned subsidiary of Home Federal Bancorp, Inc. of Louisiana (NASDAQ: HFBL), today announced plans to pay up to a $1,000 cash bonus to eligible non-exempt and non-commissioned employees.  Approximately 60% of HFB’s employees will receive a bonus. “When the Coronavirus threat emerged, our Senior Management Team made a commitment to ensure the safety and well-being of our employees.  To us, this meant that every employee would keep his or her job, salary and benefits,” said Jim Barlow, President and CEO of Home Federal Bank.   “When we began to see a resurgence in the number of local Coronavirus cases, we made plans to create a bonus package for our non-exempt employees, who may be affected by the virus in some way.  Our employees consistently go...

JACKSONVILLE, Fla., July 31, 2020 (GLOBE NEWSWIRE) — CSX (NASDAQ: CSX) announced today the publication of its 2019 Environmental, Social and Governance (ESG) report, highlighting the company’s sustainability performance in the areas of safety, environment, people, communities and governance.“CSX’s goal is to be the best-run railroad in North America and fundamental to that goal is strong ESG performance,” said James M. Foote, president and chief executive officer. “Since our last comprehensive ESG report was published, CSX has undergone a significant transformation. We revolutionized our operating model, wholly transforming the company’s financial and ESG profile. The 2019 report illustrates how the transformation has allowed us to achieve new levels of reliability, customer service, safety, and environmental efficiency.”The 2019...

TERRE HAUTE, Ind., July 31, 2020 (GLOBE NEWSWIRE) — First Financial Corporation (NASDAQ:THFF) today announced results for the second quarter of 2020. For the three months ending June 30, 2020:Net income was $11.9 million compared to $12.6 million for the same period of 2019; Diluted net income per common share of $0.87 compared to $1.02 for the same period of 2019; and Return on average assets was 1.10% compared to 1.66% for the three months ended June 30, 2019.The Corporation further reported results for the six months ending June 30, 2020:Net income was $24.1 million compared to $22.3 million for the same period of 2019; Diluted net income per common share of $1.76 compared to $1.81 for the same period of 2019; and Return on average assets was 1.16% compared to 1.47% for the six months ended June 30, 2019.“In light of COVID-19...

VANCOUVER, British Columbia, July 31, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has voluntarily filed a technical report prepared pursuant to National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) for its Egina gold project. The independent technical report, entitled NI 43-101 Technical Report: Egina Alluvial Project, Pilbara Region, Western Australia (the “Egina Technical Report”), with an effective date of April 30, 2020 and an issue date of July 30, 2020, was prepared for Novo by Dr. Quinton Hennigh (PGeo) and Dr. Simon Dominy (FAusIMM (CP) FAIG (RPGeo)) as co-authors. Dr. Hennigh and Dr. Dominy are qualified persons as defined under NI 43-101. The Egina Technical Report will be available under the Company’s profile...